Skip to Content

JHancock Blue Chip Growth NAV JHBCX

Medalist Rating as of | See John Hancock Investment Hub
  • NAV / 1-Day Return 53.47  /  +0.24 %
  • Total Assets 4.0 Bil
  • Adj. Expense Ratio
    0.770%
  • Expense Ratio 0.770%
  • Distribution Fee Level Average
  • Share Class Type No Load
  • Category Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield
  • Turnover 14%

USD | NAV as of Apr 17, 2024 | 1-Day Return as of Apr 17, 2024, 12:03 AM GMT+0

Morningstar’s Analysis JHBCX

Will JHBCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Finding its stride.

Senior Analyst Adam Sabban

Adam Sabban

Senior Analyst

Summary

John Hancock Blue Chip Growth—which is managed in parallel with T. Rowe Price Blue Chip Growth—earns Morningstar Medalist Ratings ranging from Silver to Neutral (depending on share-class fees) because of the strength of its vast team and a sensible framework guided by deep research.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings JHBCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 63.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

14.15 564.9 Mil
Technology

NVIDIA Corp

9.02 359.9 Mil
Technology

Amazon.com Inc

8.58 342.7 Mil
Consumer Cyclical

Apple Inc

8.43 336.4 Mil
Technology

Alphabet Inc Class C

5.89 235.0 Mil
Communication Services

Meta Platforms Inc Class A

5.00 199.6 Mil
Communication Services

Eli Lilly and Co

3.47 138.5 Mil
Healthcare

Visa Inc Class A

3.19 127.3 Mil
Financial Services

UnitedHealth Group Inc

2.75 109.8 Mil
Healthcare

Mastercard Inc Class A

2.64 105.2 Mil
Financial Services